Skip to main content

Table 1 Demographic and biochemical characteristics of the study participants (N = 463)

From: Macrocytic anemia is associated with the severity of liver impairment in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective cross-sectional study

Variable

Macrocytic anemia

Normocytic anemia

Microcytic anemia

P value

Number of subjects

123

304

36

 

Mean corpuscular volume, fL

102.7 ± 2.6

91.2 ± 5.1

74.2 ± 4.6†¥

< 0.001

Age, years

56.1 ± 7.6

53.9 ± 7.1

51.8 ± 6.2

0.002

Male, n(%)

78(63.4)

191(62.8)

25(69.4)

0.738

Drinking, n(%)

24(19.5)

74(24.3)

13(36.1)

0.118

Smoking, n(%)

48(39.0)

107(35.2)

15(41.7)

0.618

Diabetes, n(%)

10(8.1)

39(12.8)

9(25.0)

0.026

Hypertension, n(%)

14(11.3)

36(11.8)

4(11.1)

0.985

Hemoglobin, g/L

 > 90

97(78.9)

230(75.7)

10(27.8)†¥

< 0.001

 60–90

21(17.1)

63(20.7)

20(55.6)†¥

< 0.001

 < 60

5(4.1)

11(3.6)

6(16.7)†¥

0.002

Total cholesterol, mmol/L

2.4 ± 0.7

2.7 ± 0.9

2.7 ± 0.8

0.012

Systolic blood pressure, mmHg

117.9 ± 17.6

117.8 ± 15.2

113.8 ± 13.8

0.350

Diastolic blood pressure, mmHg

72.6 ± 11.7

73.4 ± 10.0

70.9 ± 8.6

0.354

Bilirubin, mg/dL

3.4 ± 3.4

2.6 ± 3.2

1.8 ± 3.4

0.011

Creatinine, mg/dL

0.8 ± 0.8

0.7 ± 0.4

0.7 ± 0.4

0.147

INR

1.5 ± 0.3

1.4 ± 0.4

1.3 ± 0.1

0.006

eGFR, mL/min/1.73m2

123.6 ± 54.5

126.9 ± 43.4

130.3 ± 39.1

0.686

Albumin

27.0 ± 4.7

29.1 ± 4.7

31.7 ± 4.8†¥

< 0.001

AST

78.3 ± 147.3

84.2 ± 196.6

41.7 ± 39.5

0.394

ALT

45.3 ± 42.4

59.4 ± 114.3

29.3 ± 31.8

0.113

ALP

122.9 ± 55.5

106.4 ± 61.1

85.2 ± 32.7

0.001

MELD score

10.8 ± 6.6

8.0 ± 5.5

6.3 ± 5.1

< 0.001

Complications, n(%)

 UGB

6(4.9)

34(11.2)

5(13.9)

0.093

 SBP

36(29.3)

75(24.7)

3(8.3)

0.037

 HE

14(11.4)

22(7.2)

3(8.3)

0.377

  1. Values are presented as mean ± standard deviation or numbers (percentage)
  2. INR international normalized ratio, eGFR estimated glomerular filtration rate, AST aspartate aminotransferase, ALT alanine aminotransferase, ALP alkaline phosphatase, MELD model for end stage liver disease, UGB upper gastrointestinal bleeding, SBP spontaneous bacterial peritonitis, HE hepatic encephalopathy
  3. P indicates the difference among the three groups. Indicates significance (P < 0.05) compared to macrocytic anemia; ¥Indicates significance (P < 0.05) compared to normocytic anemia